Variant report

Variant	esv3386643
Chromosome Location	chr20:13201202-13203450
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:268)
CpG islands
(count:1403)
Chromatin interactive
region (count:0)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:268 , 50 per page) page: 1 2 3 4 5 6

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr20:13200843-13201401	H1-hESC	embryonic stem cell:	n/a	n/a
2	BCLAF1	chr20:13202292-13202561	GM12878	blood:	n/a	chr20:13202323-13202336 chr20:13202322-13202335
3	BHLHE40	chr20:13202575-13202811	A549	lung:	n/a	chr20:13202735-13202744 chr20:13202736-13202745 chr20:13202734-13202743 chr20:13202735-13202744
4	BHLHE40	chr20:13202299-13202958	HepG2	liver:	n/a	chr20:13202735-13202744 chr20:13202736-13202745 chr20:13202734-13202743 chr20:13202735-13202744
5	BHLHE40	chr20:13202406-13202798	GM12878	blood:	n/a	chr20:13202735-13202744 chr20:13202736-13202745 chr20:13202734-13202743 chr20:13202735-13202744
6	CEBPB	chr20:13202439-13202467	HepG2	liver:	n/a	n/a
7	CEBPD	chr20:13202289-13202596	HepG2	liver:	n/a	n/a
8	CHD1	chr20:13202420-13202514	H1-hESC	embryonic stem cell:	n/a	n/a
9	CHD2	chr20:13201013-13201213	HepG2	liver:	n/a	n/a
10	CHD2	chr20:13202413-13202814	H1-hESC	embryonic stem cell:	n/a	n/a
11	CHD2	chr20:13202453-13202838	HepG2	liver:	n/a	n/a
12	CHD2	chr20:13203130-13203304	H1-hESC	embryonic stem cell:	n/a	chr20:13203144-13203154
13	CREB1	chr20:13202143-13202667	A549	lung:	n/a	n/a
14	CREB1	chr20:13200585-13201271	H1-hESC	embryonic stem cell:	n/a	n/a
15	CREB1	chr20:13202290-13202637	H1-hESC	embryonic stem cell:	n/a	n/a
16	CREB1	chr20:13202232-13202955	HepG2	liver:	n/a	n/a
17	CREB1	chr20:13200669-13201239	H1-hESC	embryonic stem cell:	n/a	n/a
18	CREB1	chr20:13202284-13202634	H1-hESC	embryonic stem cell:	n/a	n/a
19	CREB1	chr20:13202298-13202504	A549	lung:	n/a	n/a
20	CTBP2	chr20:13200367-13201967	H1-hESC	embryonic stem cell:	n/a	n/a
21	CTBP2	chr20:13202338-13203480	H1-hESC	embryonic stem cell:	n/a	n/a
22	CTCF	chr20:13201380-13201530	HepG2	liver:	n/a	n/a
23	CTCF	chr20:13201580-13201730	NHEK	skin:	n/a	n/a
24	CTCF	chr20:13202432-13202455	GM12878	blood:	n/a	n/a
25	CTCF	chr20:13201306-13201312	MCF-7	breast:	n/a	n/a
26	CTCF	chr20:13202400-13202550	GM12867	blood:	n/a	n/a
27	CTCF	chr20:13202420-13202570	GM12873	blood:	n/a	n/a
28	CTCF	chr20:13202320-13202470	GM12871	blood:	n/a	n/a
29	CTCF	chr20:13201603-13201640	ProgFib	skin:	n/a	n/a
30	CTCF	chr20:13202340-13202490	NHDF-neo	bronchial:	n/a	n/a
31	CTCF	chr20:13201420-13201570	HRE	kidney:	n/a	n/a
32	CTCF	chr20:13202400-13202550	GM12865	blood:	n/a	n/a
33	CTCF	chr20:13201558-13201667	MCF-7	breast:	n/a	n/a
34	CTCF	chr20:13202400-13202550	GM12866	blood:	n/a	n/a
35	CTCF	chr20:13202320-13202470	GM12875	blood:	n/a	n/a
36	CTCF	chr20:13202340-13202490	GM12866	blood:	n/a	n/a
37	CTCF	chr20:13201600-13201645	H1-hESC	embryonic stem cell:	n/a	n/a
38	CTCF	chr20:13201526-13201706	MCF-7	breast:	n/a	n/a
39	CTCF	chr20:13201260-13201410	HRE	kidney:	n/a	n/a
40	CTCF	chr20:13202359-13202537	Fibrobl	skin:	n/a	n/a
41	CTCF	chr20:13202320-13202470	BJ	skin:	n/a	n/a
42	CTCF	chr20:13202340-13202490	HepG2	liver:	n/a	n/a
43	CTCF	chr20:13202390-13202549	MCF-7	breast:	n/a	n/a
44	CTCF	chr20:13202380-13202530	GM12873	blood:	n/a	n/a
45	CTCF	chr20:13202373-13202511	H1-hESC	embryonic stem cell:	n/a	n/a
46	CTCF	chr20:13202340-13202490	AG04449	skin:	n/a	n/a
47	CTCF	chr20:13202391-13202474	GM10266	blood:	n/a	n/a
48	CTCF	chr20:13202340-13202490	BJ	skin:	n/a	n/a
49	CTCF	chr20:13202340-13202490	AG09319	gingival:	n/a	n/a
50	CTCF	chr20:13202340-13202490	GM12868	blood:	n/a	n/a

(count:1403 , 50 per page) page: 1 2 3 4 5 6 7 ... 29

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr20:13201551-13201601	IMR90	lung:	fetal
2	chr20:13201193-13201243	AG09309	skin:	n/a
3	chr20:13201216-13201266	AG04449	skin:	fetal
4	chr20:13202489-13202539	SK-N-SH_RA	brain:	n/a
5	chr20:13201662-13201712	GM12878	blood:	n/a
6	chr20:13201551-13201601	SK-N-SH_RA	brain:	n/a
7	chr20:13202476-13202526	ECC-1	luminal epithelium:	n/a
8	chr20:13201216-13201266	MCF-7	breast:	n/a
9	chr20:13201655-13201705	RPTEC	kidney:	n/a
10	chr20:13201342-13201392	HUVEC	blood vessel:	n/a
11	chr20:13202222-13202272	AG04450	lung:	fetal
12	chr20:13202476-13202526	HIPEpiC	eye:	n/a
13	chr20:13202702-13202752	HCF	heart:	n/a
14	chr20:13201205-13201255	HRE	kidney:	n/a
15	chr20:13201353-13201403	HAEpiC	amniotic membrane:	n/a
16	chr20:13201349-13201399	GM12892	blood:	n/a
17	chr20:13202225-13202275	AoSMC	blood vessel:	n/a
18	chr20:13201456-13201506	ProgFib	skin:	n/a
19	chr20:13202222-13202272	A549	lung:	n/a
20	chr20:13201844-13201894	HCM	heart:	n/a
21	chr20:13201353-13201403	SK-N-SH	brain:	n/a
22	chr20:13201225-13201275	GM12878	blood:	n/a
23	chr20:13201342-13201392	HPAEpiC	pulmonary alveolar:	n/a
24	chr20:13201216-13201266	PANC-1	pancreas:	n/a
25	chr20:13202702-13202752	PFSK-1	brain:	n/a
26	chr20:13201670-13201720	SAEC	small airway:	n/a
27	chr20:13202222-13202272	HRCEpiC	kidney:	n/a
28	chr20:13202489-13202539	HRPEpiC	eye:	n/a
29	chr20:13201216-13201266	T-47D	breast:	n/a
30	chr20:13202222-13202272	H1-hESC	embryonic stem cell:	embryo
31	chr20:13201650-13201700	T-47D	breast:	n/a
32	chr20:13201844-13201894	NB4	blood:	n/a
33	chr20:13201844-13201894	A549	lung:	n/a
34	chr20:13202222-13202272	ovcar-3	ovarian:	n/a
35	chr20:13201353-13201403	Hepatocyte	liver:	n/a
36	chr20:13202225-13202275	HPAEpiC	pulmonary alveolar:	n/a
37	chr20:13201342-13201392	AG09309	skin:	n/a
38	chr20:13202489-13202539	HAEpiC	amniotic membrane:	n/a
39	chr20:13202437-13202487	HMEC	breast:	n/a
40	chr20:13201655-13201705	ovcar-3	ovarian:	n/a
41	chr20:13202225-13202275	SK-N-SH	brain:	n/a
42	chr20:13202489-13202539	ovcar-3	ovarian:	n/a
43	chr20:13201349-13201399	Hepatocyte	liver:	n/a
44	chr20:13201216-13201266	HCF	heart:	n/a
45	chr20:13201655-13201705	IMR90	lung:	fetal
46	chr20:13202222-13202272	SK-N-SH	brain:	n/a
47	chr20:13201328-13201378	RPTEC	kidney:	n/a
48	chr20:13202225-13202275	HRE	kidney:	n/a
49	chr20:13201328-13201378	HRCEpiC	kidney:	n/a
50	chr20:13202489-13202539	NHBE	bronchial:	n/a

No data

Variant related genes	Relation type
ISM1	TF binding region
ISM1	CpG island

Extended variants
information (count: 76 )
Associated
traits (count: 54 )

Variant overlapped rSNPs/rCNVs (count:76 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs35907305	chr20:13201238-13201239	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs6074569	chr20:13201257-13201258	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
3	rs183644632	chr20:13201290-13201291	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs372939151	chr20:13201298-13201299	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs188355112	chr20:13201304-13201305	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs369279814	chr20:13201305-13201306	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs182280301	chr20:13201335-13201336	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
8	rs533038225	chr20:13201336-13201337	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Active TSS Flanking Active TSS Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
9	rs6041958	chr20:13201434-13201435	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs556672623	chr20:13201450-13201451	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs576673888	chr20:13201466-13201467	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
12	rs539361223	chr20:13201508-13201509	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs187331266	chr20:13201521-13201522	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs6041959	chr20:13201570-13201571	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Transcr. at gene 5' and 3'	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
15	rs6041960	chr20:13201629-13201630	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs571106797	chr20:13201647-13201648	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs559290628	chr20:13201655-13201656	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
18	rs372748246	chr20:13201670-13201671	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
19	rs540030511	chr20:13201675-13201676	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
20	rs374948047	chr20:13201679-13201680	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs13036520	chr20:13201724-13201725	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs13037698	chr20:13201725-13201726	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs541424225	chr20:13201728-13201729	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs561385093	chr20:13201790-13201791	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs71330293	chr20:13201822-13201823	Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
26	rs543259815	chr20:13201847-13201848	Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
27	rs75223385	chr20:13201866-13201867	Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
28	rs373423999	chr20:13201867-13201868	Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
29	rs191786640	chr20:13201869-13201870	Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
30	rs563316134	chr20:13201872-13201873	Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
31	rs529120350	chr20:13201899-13201900	Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs145418314	chr20:13201909-13201910	Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs563536828	chr20:13201963-13201964	Active TSS Bivalent/Poised TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs551720372	chr20:13202067-13202068	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs532200570	chr20:13202083-13202084	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs112047555	chr20:13202093-13202094	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs185866750	chr20:13202171-13202172	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs559205687	chr20:13202256-13202257	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
39	rs528089953	chr20:13202276-13202277	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs113569834	chr20:13202315-13202316	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs568067003	chr20:13202322-13202323	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs530587741	chr20:13202336-13202337	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs149074566	chr20:13202358-13202359	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs570277086	chr20:13202361-13202362	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs56184254	chr20:13202367-13202368	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs559328962	chr20:13202369-13202370	Active TSS Bivalent/Poised TSS Flanking Active TSS Enhancers Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs553664054	chr20:13202516-13202517	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs371037381	chr20:13202584-13202585	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs535041758	chr20:13202586-13202587	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Transcr. at gene 5' and 3' Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs189940458	chr20:13202614-13202615	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:54)

Disease	PMID	Source
Breast cancer	16397240	CNVD
abortions and stillbirths	19751515	CNVD
Wilms tumour	21544195	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Breast cancer	16272173	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	19627613	CNVD
colon cancer	17210682	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	21080181	CNVD
Thyroid cancer	19087340	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Colorectal cancer	19359472	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Human rectal carcinomas	16397240	CNVD
Olfactory neuroblastoma	18408657	CNVD
Central neurocytomas	17123091	CNVD
Colorectal cancer	16272173	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Colorectal cancer	21645411	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Autism	22495311	CNVD
Glaucoma	21310917	CNVD
Alagille syndrome	22470819	CNVD
Lung cancer	16773561	CNVD
Renal cell carcinoma	18765545	CNVD
Alagille syndrome	17576883	CNVD
Anaplastic large cell lymphoma	18179710	CNVD
Prostate cancer	18632612	CNVD
Ewing''s sarcoma	18628472	CNVD
Glioblastoma multiforme	18628472	CNVD
Leukemia	18628472	CNVD
Myelofibrosis	22110671	CNVD
Kabuki syndrome	21720541	CNVD
Glioblastoma multiforme	22286061	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Neurocytoma	17123091	CNVD
Autism	22102821	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:446 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr20:13199800-13201400	Bivalent Enhancer	Fetal Brain Male	brain
2	chr20:13199800-13201600	Bivalent/Poised TSS	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
3	chr20:13199800-13201800	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
4	chr20:13199800-13203400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
5	chr20:13199800-13203600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
6	chr20:13200000-13201400	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
7	chr20:13200000-13201600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
8	chr20:13200000-13203000	Bivalent/Poised TSS	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
9	chr20:13200000-13203600	Bivalent/Poised TSS	H9 Cell Line	embryonic stem cell
10	chr20:13200000-13203600	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
11	chr20:13200000-13203600	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
12	chr20:13200200-13201800	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
13	chr20:13200200-13203000	Active TSS	Aorta	Aorta
14	chr20:13200200-13203200	Bivalent/Poised TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
15	chr20:13200200-13203200	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
16	chr20:13200400-13201400	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
17	chr20:13200400-13201400	Flanking Bivalent TSS/Enh	Primary T cells from cord blood	blood
18	chr20:13200400-13201400	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
19	chr20:13200400-13201400	Flanking Bivalent TSS/Enh	Primary T helper cells PMA-I stimulated	--
20	chr20:13200400-13201400	Flanking Bivalent TSS/Enh	Brain Hippocampus Middle	brain
21	chr20:13200400-13201400	Flanking Bivalent TSS/Enh	Fetal Brain Female	brain
22	chr20:13200400-13201400	Flanking Bivalent TSS/Enh	Fetal Stomach	stomach
23	chr20:13200400-13201600	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
24	chr20:13200400-13201600	Flanking Bivalent TSS/Enh	Primary T cells fromperipheralblood	blood
25	chr20:13200400-13201600	Flanking Bivalent TSS/Enh	Skeletal Muscle Male	skeletal muscle
26	chr20:13200400-13201800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Female	--
27	chr20:13200400-13201800	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells G-CSF-mobilized Male	--
28	chr20:13200400-13201800	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin03	Skin
29	chr20:13200400-13201800	Bivalent/Poised TSS	Brain Anterior Caudate	brain
30	chr20:13200400-13201800	Bivalent/Poised TSS	Brain Cingulate Gyrus	brain
31	chr20:13200400-13201800	Flanking Bivalent TSS/Enh	Fetal Adrenal Gland	Adrenal Gland
32	chr20:13200600-13201400	Flanking Bivalent TSS/Enh	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr20:13200600-13201400	Flanking Bivalent TSS/Enh	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
34	chr20:13200600-13201400	Flanking Bivalent TSS/Enh	Duodenum Mucosa	Duodenum
35	chr20:13200600-13201400	Flanking Active TSS	Pancreas	Pancrea
36	chr20:13200600-13201400	Flanking Bivalent TSS/Enh	Rectal Mucosa Donor 31	rectum
37	chr20:13200600-13201400	Bivalent/Poised TSS	HSMM	muscle
38	chr20:13200600-13201600	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
39	chr20:13200600-13201600	Flanking Bivalent TSS/Enh	Muscle Satellite Cultured Cells	--
40	chr20:13200600-13201600	Flanking Bivalent TSS/Enh	Ganglion Eminence derived primary cultured neurospheres	brain
41	chr20:13200600-13201600	Flanking Bivalent TSS/Enh	Foreskin Melanocyte Primary Cells skin01	Skin
42	chr20:13200600-13201600	Flanking Active TSS	Liver	Liver
43	chr20:13200600-13201600	Flanking Bivalent TSS/Enh	Fetal Intestine Large	intestine
44	chr20:13200600-13201600	Flanking Bivalent TSS/Enh	Fetal Intestine Small	intestine
45	chr20:13200600-13201600	Flanking Bivalent TSS/Enh	Fetal Muscle Leg	muscle
46	chr20:13200600-13201600	Flanking Bivalent TSS/Enh	Rectal Mucosa Donor 29	rectum
47	chr20:13200600-13201600	Bivalent Enhancer	Stomach Mucosa	stomach
48	chr20:13200600-13201600	Flanking Active TSS	Dnd41	blood
49	chr20:13200600-13201600	Flanking Bivalent TSS/Enh	HepG2	liver
50	chr20:13200600-13201800	Flanking Bivalent TSS/Enh	iPS DF 19.11 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links